These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34884940)

  • 1. Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression.
    Koh HS; Lee S; Lee HJ; Min JW; Iwatsubo T; Teunissen CE; Cho HJ; Ryu JH
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease.
    Islam MA; Sultana OF; Bandari M; Kshirsagar S; Manna PR; Reddy PH
    Ageing Res Rev; 2024 Sep; 100():102459. PubMed ID: 39153602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
    Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
    Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
    Kumar S; Vijayan M; Reddy PH
    Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    Chum PP; Hakim MA; Behringer EJ
    J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer's disease.
    Fu Y; Hu X; Zheng C; Sun G; Xu J; Luo S; Cao P
    Metab Brain Dis; 2019 Oct; 34(5):1355-1363. PubMed ID: 31134481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
    Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy.
    Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
    Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
    Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
    CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
    Sha S; Shen X; Cao Y; Qu L
    Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
    Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
    Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p47
    Gong P; Chen YQ; Lin AH; Zhang HB; Zhang Y; Ye RD; Yu Y
    Alzheimers Res Ther; 2020 Nov; 12(1):146. PubMed ID: 33183342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease.
    He B; Chen W; Zeng J; Tong W; Zheng P
    J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
    Lian X; Zhang X; Chen W; Xue F; Wang G
    Brain Res; 2024 Jan; 1822():148612. PubMed ID: 37778649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.
    Kong ZH; Chen X; Hua HP; Liang L; Liu LJ
    J Mol Neurosci; 2017 Dec; 63(3-4):385-395. PubMed ID: 29034441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.